Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ajinomoto
Pharma
Merck-Curon, Legend, Amgen—Fierce Pharma Asia
Merck licensed a bispecific from Curon. Legend is taking a close look at its business. The FDA flagged missing adverse events in an Amgen filing.
Angus Liu
Aug 16, 2024 8:59am
Ajinomoto cuts staff in California to streamline manufacturing
Aug 12, 2024 8:51am
Novartis-Legend, Astellas, Ajinomoto—Fierce Pharma Asia
Nov 17, 2023 8:00am
CDMO Ajinomoto shells out $620M in Forge Biologics buy
Nov 13, 2023 11:09am
FDA rejects Outlook's Avastin reformulation for eye disease
Aug 30, 2023 11:30am
Takeda-CSL, Daiichi, Legend-J&J and more—Fierce Pharma Asia
Apr 9, 2021 10:25am
